Biomarkers in cancer staging, prognosis and treatment selection (Q28278305)

The human plasma proteome: history, character, and diagnostic prospects

Europe PubMed Central

title

Biomarkers in cancer staging, prognosis and treatment selection (English)

0 references

0 references

Joseph A Ludwig

1

0 references

John N Weinstein

series ordinal

2

0 references

language of work or name

English

0 references

publication date

November 2005

0 references

published in

Nature Reviews Cancer

0 references

volume

5

0 references

issue

11

0 references

page(s)

845-56

0 references

cites work

1 reference

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 April 2017

1 reference

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 April 2017

1 reference

p53, the cellular gatekeeper for growth and division

21 April 2017

1 reference

Mutations in the p53 gene occur in diverse human tumour types

21 April 2017

1 reference

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

21 April 2017

1 reference

Translating the Histone Code

21 April 2017

1 reference

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 April 2017

1 reference

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 April 2017

1 reference

Molecular portraits of human breast tumours

21 April 2017

1 reference

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 April 2017

1 reference

A gene-expression signature as a predictor of survival in breast cancer

21 April 2017

1 reference

Gene expression profiling predicts clinical outcome of breast cancer

21 April 2017

1 reference

Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer

21 April 2017

1 reference

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 April 2017

1 reference

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 April 2017

1 reference

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

21 April 2017

1 reference

Facile detection of mitochondrial DNA mutations in tumors and bodily fluids

21 April 2017

1 reference

A molecular signature of metastasis in primary solid tumors

21 April 2017

1 reference

Molecular classification of cutaneous malignant melanoma by gene expression profiling

21 April 2017

1 reference

Diversity of gene expression in adenocarcinoma of the lung

21 April 2017

1 reference

TNM: evolution and relation to other prognostic factors

21 April 2017

1 reference

The promise of biomarkers in cancer screening and detection

21 January 2018

1 reference

Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma

21 January 2018

1 reference

Gene expression profiles of human breast cancer progression

21 January 2018

1 reference

Automated cervical cytology: meta-analyses of the performance of the PAPNET system.

21 January 2018

1 reference

Can computer-aided detection with double reading of screening mammograms help decrease the false-negative rate? Initial experience

21 January 2018

1 reference

Pulmonary nodules at chest CT: effect of computer-aided diagnosis on radiologists' detection performance.

21 January 2018

1 reference

Computer-aided detection and diagnosis at the start of the third millennium

21 January 2018

1 reference

In vivo detection and imaging of phosphatidylserine expression during programmed cell death

21 January 2018

1 reference

Clinical role of FDG PET in evaluation of cancer patients

21 January 2018

1 reference

Revision of the American Joint Committee on Cancer staging system for breast cancer

21 January 2018

1 reference

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

The genetics and genomics of cancer

21 January 2018

1 reference

Retrospective analysis of the predictive factors associated with the response and survival benefit of gefitinib in patients with advanced non-small-cell lung cancer

21 January 2018

1 reference

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

21 January 2018

1 reference

Pharmacogenetics and cancer therapy

21 January 2018

1 reference

The use and development of germline polymorphisms in clinical oncology

21 January 2018

1 reference

Emerging molecular markers of cancer.

21 January 2018

1 reference

Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives

21 January 2018

1 reference

Dissecting the metastatic cascade

21 January 2018

1 reference

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

21 January 2018

1 reference

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

21 January 2018

1 reference

A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands

21 January 2018

1 reference

Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.

21 January 2018

1 reference

Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis

21 January 2018

1 reference

Molecular Detection of Tumor Cells in Bronchoalveolar Lavage Fluid From Patients With Early Stage Lung Cancer

21 January 2018

1 reference

Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients

21 January 2018

1 reference

Pharmacogenomics--teaching old drugs new tricks.

21 January 2018

1 reference

DNA methylation and cancer therapy: new developments and expectations

21 January 2018

1 reference

Preferential response of cancer cells to zebularine.

21 January 2018

1 reference

A review of depsipeptide and other histone deacetylase inhibitors in clinical trials

21 January 2018

1 reference

T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance

21 January 2018

1 reference

DNA-microarray analysis of brain cancer: molecular classification for therapy

21 January 2018

1 reference

Genome changes and gene expression in human solid tumors

21 January 2018

1 reference

Serial analysis of gene expression

21 January 2018

1 reference

Lab-on-a-chip for drug development

21 January 2018

1 reference

An information-intensive approach to the molecular pharmacology of cancer.

21 January 2018

1 reference

Reconstruction of cellular signalling networks and analysis of their properties

21 January 2018

1 reference

Clinical proteomics: translating benchside promise into bedside reality

21 January 2018

1 reference

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

21 January 2018

1 reference

Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients

21 January 2018

1 reference

Gene-expression profiling in human cutaneous melanoma

21 January 2018

1 reference

Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes

21 January 2018

1 reference

Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis

21 January 2018

1 reference

Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon

21 January 2018

1 reference

2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers

21 January 2018

1 reference

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays

21 January 2018

1 reference

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

21 January 2018

1 reference

Proteomic applications for the early detection of cancer

21 January 2018

1 reference

Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates

21 January 2018

1 reference

Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins

21 January 2018

1 reference

Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots

21 January 2018

1 reference

Self-assembled nanoscale biosensors based on quantum dot FRET donors

21 January 2018

1 reference

New approaches to the understanding of the molecular basis of oral cancer

21 January 2018

1 reference

Phases of biomarker development for early detection of cancer

21 January 2018

1 reference

Cancer biomarker validation: standards and process: roles for the National Institute of Standards and Technology (NIST).

21 January 2018

1 reference

Microarray data--the US FDA, industry and academia

21 January 2018

1 reference

Postgenomic protein analysis: the next bend in the river

21 January 2018

1 reference

Ovarian cancer: the clinical role of US, CT, and MRI.

21 January 2018

1 reference

Utility of tumor markers in determining resectability of pancreatic cancer.

21 January 2018

1 reference

Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk

21 January 2018

1 reference

Genetic polymorphisms of XRCC1 and risk of gastric cancer

21 January 2018

1 reference

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

21 January 2018

1 reference

p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity

21 January 2018

1 reference

Haplotype and linkage disequilibrium architecture for human cancer-associated genes

21 January 2018

1 reference

High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines

21 January 2018

1 reference

Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.

21 January 2018

1 reference

Overview: viral agents and cancer

21 January 2018

1 reference

A controlled trial of a human papillomavirus type 16 vaccine

21 January 2018

1 reference

Somatic mutations of the mitochondrial genome in human colorectal tumours

21 January 2018

1 reference

Mitochondrial genome instability in human cancers

21 January 2018

1 reference

'Omic' and hypothesis-driven research in the molecular pharmacology of cancer

21 January 2018

1 reference

Virologic and Immunologic Parameters that Predict Clinical Response of AIDS-Associated Kaposi's Sarcoma to Highly Active Antiretroviral Therapy

21 January 2018

1 reference

Haplotype tagging for the identification of common disease genes

21 January 2018

1 reference

Issues and barriers to development of clinically useful tumor markers: a development pathway proposal

21 January 2018

1 reference

Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin

31 March 2020

1 reference

ERBB2 oncogene in human breast cancer and its clinical significance

31 March 2020

1 reference

Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stage

31 March 2020

1 reference

Circulating tumor cells in patients with breast cancer dormancy

31 March 2020

1 reference

Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck

31 March 2020

1 reference

Assessing the use of p16(INK4a) promoter gene methylation in serum for detection of bladder cancer

31 March 2020

1 reference

Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients

31 March 2020

1 reference

High frequency of DAP-kinase gene promoter methylation in colorectal cancer specimens and its identification in serum

31 March 2020

1 reference

Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers.

31 March 2020

1 reference

31 March 2020

1 reference

Nanoscale quantum dots hold promise for cancer applications

31 March 2020

1 reference

Rules of evidence for cancer molecular-marker discovery and validation

31 March 2020

1 reference

Regulatory issues in tumor marker development

31 March 2020

1 reference

Regulatory issues related to marker development

31 March 2020

1 reference

The usefulness of CA15.3, mucin-like carcinoma-associated antigen and carcinoembryonic antigen in determining the clinical course in patients with metastatic breast cancer

31 March 2020

1 reference

Frequency of breast cancer attributable to BRCA1 in a population-based series of American women

31 March 2020

1 reference

Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells

31 March 2020

1 reference

Alteration of mitochondrial DNA in human oncocytomas

31 March 2020

1 reference

31 March 2020

1 reference